Priming with GM-CSF for acute myelogenous leukemia (AML): GOELAM data.
Witz
F
F
Hématologie Clinique, Hôpital de Brabois, 54511 Vandoeuvre, France.
Harousseau
J L
JL
Guilhot
F
F
Cahn
J Y
JY
Witz
B
B
Loos
C
C
Chevalier
M P
MP
Guibon
O
O
Berthaud
P
P
Lioure
B
B
D000293:Adolescent; D000328:Adult; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000627:therapeutic use; D004334:Drug Administration Schedule; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008875:Middle Aged; D011994:Recombinant Proteins
D000964:Antimetabolites, Antineoplastic; D011994:Recombinant Proteins; D003561:Cytarabine; D016178:Granulocyte-Macrophage Colony-Stimulating Factor